drugset / Trial / NCT01060137
Fentanyl Matrix in Lung Cancer Pain
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the usefulness of fentanyl matrix by assessing patients' satisfaction when administrating fentanyl matrix, a background pain treatment, and a breakthrough pain treatment to lung cancer patients who complain of pain. Fentanyl matrix is designed to deliver medication at a nearly constant amount per unit time into the body through the skin for 3 days (72 hours).
Timeline
- Start
- 2006-05
- Primary completion
- 2007-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | 12.5 ug | Other |
| Subject | Fentanyl | Other / unclassified | 25 ug | Other |